ATE86660T1 - Attenuierte viren. - Google Patents

Attenuierte viren.

Info

Publication number
ATE86660T1
ATE86660T1 AT90300516T AT90300516T ATE86660T1 AT E86660 T1 ATE86660 T1 AT E86660T1 AT 90300516 T AT90300516 T AT 90300516T AT 90300516 T AT90300516 T AT 90300516T AT E86660 T1 ATE86660 T1 AT E86660T1
Authority
AT
Austria
Prior art keywords
attached viruses
viruses
attached
rhinovirus
vaccine
Prior art date
Application number
AT90300516T
Other languages
English (en)
Inventor
Jeffrey William Almond
Reading
Philip David Minor
Standards And Contr Biological
Michael Anthony Skinner
Original Assignee
British Tech Group
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Tech Group filed Critical British Tech Group
Application granted granted Critical
Publication of ATE86660T1 publication Critical patent/ATE86660T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/125Picornaviridae, e.g. calicivirus
    • A61K39/13Poliovirus
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32311Enterovirus
    • C12N2770/32361Methods of inactivation or attenuation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32634Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32611Poliovirus
    • C12N2770/32661Methods of inactivation or attenuation
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/32011Picornaviridae
    • C12N2770/32711Rhinovirus
    • C12N2770/32761Methods of inactivation or attenuation
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Gas Separation By Absorption (AREA)
  • External Artificial Organs (AREA)
  • Saccharide Compounds (AREA)
  • Respiratory Apparatuses And Protective Means (AREA)
AT90300516T 1989-01-18 1990-01-18 Attenuierte viren. ATE86660T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB898901093A GB8901093D0 (en) 1989-01-18 1989-01-18 Attenuated viruses

Publications (1)

Publication Number Publication Date
ATE86660T1 true ATE86660T1 (de) 1993-03-15

Family

ID=10650229

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90300516T ATE86660T1 (de) 1989-01-18 1990-01-18 Attenuierte viren.

Country Status (13)

Country Link
US (1) US5298413A (de)
EP (1) EP0383434B1 (de)
JP (1) JPH04502706A (de)
AT (1) ATE86660T1 (de)
AU (1) AU649585B2 (de)
CA (1) CA2045650A1 (de)
DE (1) DE69001026T2 (de)
DK (1) DK0383434T3 (de)
ES (1) ES2054230T3 (de)
GB (2) GB8901093D0 (de)
NZ (1) NZ232151A (de)
WO (1) WO1990008186A1 (de)
ZA (1) ZA90325B (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5298416A (en) * 1989-01-18 1994-03-29 British Technology Group Ltd. Attenuated polioviruses
GB8901094D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
JPH05508554A (ja) * 1990-11-06 1993-12-02 アメリカ合衆国 弱毒化生ワクチン中の病毒性復帰変異体の試験法
GB9107563D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Thermostable viruses
GB9107552D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Attenuated viruses
GB9323819D0 (en) * 1993-11-19 1994-01-05 Smithkline Beecham Biolog Anlytical method
US5513144A (en) * 1995-02-13 1996-04-30 Micron Technology, Inc. On-chip memory redundancy circuitry for programmable non-volatile memories, and methods for programming same
GB9705669D0 (en) * 1997-03-19 1997-05-07 British Tech Group Attenuated polioviruses
GB9817082D0 (en) * 1998-08-06 1998-10-07 Btg Int Ltd Attenuated poliovirus vaccine
GB201700825D0 (en) * 2017-01-17 2017-03-01 Sec Dep For Health Poliovaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60207582A (ja) * 1984-03-30 1985-10-19 Nippon Porio Kenkyusho 組換えプラスミド
GB8800100D0 (en) * 1988-01-05 1988-02-10 Almond J W Attenuated viruses
ATE121779T1 (de) * 1988-01-11 1995-05-15 American Cyanamid Co Nichtzurückschlagende rns-viren.
GB8901094D0 (en) * 1989-01-18 1989-03-15 Almond Jeffrey W Attenuated viruses
GB9107552D0 (en) * 1991-04-10 1991-05-29 Macadam Andrew J Attenuated viruses

Also Published As

Publication number Publication date
DK0383434T3 (da) 1993-04-13
GB9001202D0 (en) 1990-03-21
EP0383434B1 (de) 1993-03-10
JPH04502706A (ja) 1992-05-21
AU649585B2 (en) 1994-05-26
EP0383434A1 (de) 1990-08-22
DE69001026T2 (de) 1993-06-17
AU5020190A (en) 1990-08-13
DE69001026D1 (de) 1993-04-15
WO1990008186A1 (en) 1990-07-26
ZA90325B (en) 1990-10-31
GB8901093D0 (en) 1989-03-15
GB2229191B (en) 1992-06-10
US5298413A (en) 1994-03-29
GB2229191A (en) 1990-09-19
CA2045650A1 (en) 1990-07-19
NZ232151A (en) 1992-11-25
ES2054230T3 (es) 1994-08-01

Similar Documents

Publication Publication Date Title
ATE92956T1 (de) Attenuierte viren.
ATE86660T1 (de) Attenuierte viren.
GB8601680D0 (en) Modification of plant viruses
DK0529584T3 (da) Viralt agens forbundet med "Mystery Swine Disease"
DK0435443T3 (da) Anvendelse af en 15-ketoprostaglandinforbindelse til forbedring af den encephaliske funktion
DK0465024T3 (da) Styring af mikrosporogenese ved anvendelse af eksternt inducerbare promotorsekvenser
ATE91902T1 (de) Hundecoronavirus-impfstoff.
ATE89860T1 (de) Attenuierte viren.
ATE121779T1 (de) Nichtzurückschlagende rns-viren.
ATE132527T1 (de) Nicht-zurückmutierende rna-viren
Mosca et al. Evaluation by Fracture Mechanics of the Relationship Between Tool-Steel Toughness and Heat Treatment
BR8306229A (pt) Processo para preparacao de 2,3-dihidro-2,2-dimetil-7-hidroxi-benzofurano
IT7982813A0 (it) Piastra di cottura avente incorporate le parti fondamentali di uno o piu' bruciatori a gas.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee